NHS Transplant Crisis Deepens as Senior Doctor Demands Major Reform

(A Doctor. Photo by BBC News)

A senior NHS official has levelled sharp criticism at the health service’s management over endemic problems in its transplant operations, calling for substantial restructuring.

In a confidential letter obtained by a news organisation, Professor Derek Manas, medical director of NHS Blood and Transplant, accused NHS England of establishing a “fragmented” system marred by staff exhaustion, inadequate accountability for underperformance, and frequent eleventh-hour procedure cancellations.

A critical stagnation defines the sector: the volume of heart and lung transplants performed annually has remained flat for three decades.

Manas highlighted a systemic mismatch between hospital-specific waiting lists, the supply of available organs, surgical capacity, and theatre availability a disconnection that perpetuates last-minute cancellations and erratic use of donated organs.

He stated that NHS England has neither actively overseen waiting lists nor pursued equitable distribution.

The UK’s position has weakened internationally.

Recent reporting revealed that the nation, once a global leader in the field, now trails comparable Western countries in heart and lung transplantation rates.

The NHS utilizes only one in ten donated lungs and one in seven donated hearts half the proportion achieved elsewhere.

Contributing factors include delayed adoption of modern technology, insufficient theatre space, insufficient intensive care capacity, and workforce shortages.

Geographic disparities compound access issues.

Wales and Northern Ireland lack dedicated heart and lung transplant centres, forcing patients to travel to England; Scotland operates a single such facility.

Waiting times fluctuate substantially, spanning eight months to four-and-a-half years depending on location.

A particular crisis has emerged in staffing: half of England’s six transplant centres have lost their leading surgeon within the past two years, with clinicians departing for international opportunities.

Manas attributed this exodus to inadequate workforce planning, resulting in burnout among surgeons and teams, recruitment obstacles, and systemic reliance on voluntary commitment.

A 2024 report compiled by foreign experts and commissioned by the previous government first documented these failings.

Though NHS England was tasked with implementing the recommendations, progress has remained slow according to surgical professionals and patient advocates.

Dr Zubir Ahmed, a Glasgow MP and kidney transplant surgeon who left government in May, has joined calls for reform.

He argued that segments of the transplant system notably free access at point of care remain world-class but that NHS Blood and Transplant should be empowered to commission services across all UK nations to accelerate organ allocation.

He rejected the notion that capacity constraints necessitate any transplant cancellations.

NHS England responded in a statement that transplant services operate within complex constraints shaped by organ availability and pledged continued efforts to expand transplant numbers, diminish geographic variation, identify eligible patients earlier, and widen access.